Novavax’s Covid-19 vaccine gets US nod as latest pandemic weapon

As the FDA approves the first Covid-19 vaccine of this kind, EU officials continue to evaluate Novavax’s shot as a booster for adults.
Photo: Dado Ruvic/Reuters/Ritzau Scanpix
Photo: Dado Ruvic/Reuters/Ritzau Scanpix
By Fiona Rutherford, bloomberg

Novavax Inc.’s Covid-19 vaccine was cleared by US regulators, giving Americans another tool against the virus as cases start to rise again.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading